MRD Monitoring in Acute Lymphoblastic Leukemia
0 Pogledi
administrator
06/15/23
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
Prikaži više
Komentari na Facebooku
Nema komentara